Journal
THORAX
Volume 74, Issue 11, Pages 1102-1105Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/thoraxjnl-2019-213522
Keywords
Obstructive sleep apnoea; continuous positive airway pressure; catecholamines; sympathetic activity; cardiovascular
Categories
Funding
- Swiss National Science Foundation [32003B_143365/1, CR23I2_149617]
- Lunge Zurich
- University of Zurich Clinical Research Priority Program Sleep and Health
- Marie Curie European Reintegration Grant within the 7th European Community Framework Programme
- Swiss National Science Foundation (SNF) [CR23I2_149617, 32003B_143365] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
The aim of this investigation was to elucidate the effect of CPAP withdrawal on neurometabolic and cardiometabolic markers in patients with obstructive sleep apnoea. We evaluated 70 patients (mean age 61 +/- 10 years, 82% men) treated with CPAP in two 2-week, parallel, randomised controlled trials. CPAP withdrawal resulted in elevated 3,4-dihydroxyphenylglycol, norepinephrine and cortisol after 2 weeks of CPAP withdrawal; however, no statistically significant changes of the renin-angiotensin-aldosterone system (RAAS) determinants were documented. In summary, CPAP withdrawal may be more prominently linked to short-term increases in sympathetic activation than hypothalamic-pituitary-adrenal axis or RAAS activation. ClinicalTrials.gov Identifier: NCT02493673 and NCT02050425.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
